Role of L-lysine HCl in immunopotentiation towards development of suitable tuberculosis vaccination

Vaccine

Volumn 21, Issue 32, 2003, Pages 4722-4727

  Dasgupta, S ^a   Bhinge, A ^b   Chandran, V ^c   Sewlikar, S ^a   Nimbkar, A ^a   Datta, D ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY BOMBAY   (India)

^b INDIAN INSTITUTE OF SCIENCE   (India)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Adjuvant; Immunopotentiation; Lysine

Indexed keywords

ALUMINUM HYDROXIDE; BCG VACCINE; CHLORIDE; INACTIVATED VACCINE; LYSINE DERIVATIVE;

ANIMAL CELL; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; BCG VACCINATION; BIOCOMPATIBILITY; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG DOSAGE FORM; EXPERIMENTATION; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOPOTENTIATION; MALE; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; TUBERCULOSIS;

EID: 0142165016     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(03)00513-9     Document Type: Article

References (20)

1. http://www.who.int/mediacentre/factsheets/who104/en/ [last visited: 14 July 2003].
2. Li Z., Howard A., Kelley C., Delogu G., Collins F., Morris S. Immunogenicity of DNA vaccines expressing tuberculosis proteins fused to tissue plasminogen activator signal sequences. Infect. Immun. 67(9):1999;4780-4786.
3. da Fonseca D.P.A.J., Joosten D., van der Zee R., Jue D.L., Singh M., Vordermeier H.M.et al. Identification of new cytotoxic T-cell epitopes on the 38-kilodalton lipoglycoprotein of Mycobacterium tuberculosis by using lipopeptides. Infect. Immun. 66(7):1998;3190-3197.
4. Hondalus M.K., Bardarov S., Russell R., Chan J., Jacobs W.R. Jr., Bloom B. Attenuation of and protection induced by a leucine auxotroph of Mycobacterium tuberculosis. Infect. Immun. 68(5):2000;2888-2898.
5. Ott G., Barchfeld G.L., Chernoff D., Radhakrishnan R., van Hoogevest P., Van Nest G. MF59: design and evaluation of a safe and potent adjuvant for human vaccines. Pharmacol. Biotechnol. 6:1995;277-296.
6. Alexander J., Brewer J.M. Adjuvants and their modes of action. Livest. Prod. Sci. 42(2-3):1995;153-162.
7. Goto N., Kato H., Maeyama J., Eto K., Yoshihara S. Studies on the toxicities of aluminum hydroxide and calcium phosphate as immunological adjuvants for vaccines. Vaccine. 11(9):1993;914-918.
8. Goto N., Kato H., Maeyama J., Shibano M., Saito T., Yamaguchi J.et al. Local tissue irritating effects and adjuvant activities of calcium phosphate and aluminum hydroxide with different physical properties. Vaccine. 15(12-13):1997;1364-1371.
9. Haglin L., Essen-Gustavsson B., Lindholm A. Hypophosphatemia induced by dietary aluminum hydroxide supplementation in growing pigs: effects on erythrocytes, myocardium, skeletal muscle and liver. Acta Vet. Scand. 35(3):1994;263-271.
10. Dupuis M., McDonald D.M., Ott G. Distribution of adjuvant MF59 and antigen gD2 after intramuscular injection in mice. Vaccine. 18(5-6):1999;434- 439.
11. Singh M., O'Hagan D. Advances in vaccine adjuvants. Nat. Biotechnol. 17(11):1999;1075-1081.
12. da Fonseca D.P., Frerichs J., Singh M., Snippe H., Verheul A.F. Induction of antibody and T-cell responses by immunization with ISCOMS containing the 38-kilodalton protein of Mycobacterium tuberculosis. Vaccine. 19(1):2000;122-131.
13. Greinert U., Ernst M., Schlaak M., Entzian P. Interleukin-12 as successful adjuvant in tuberculosis treatment. Eur. Respir. J. 17(5):2001;1049-1051.
14. Datta D., Kundu P.K., Biswas S., Dasgupta S., Bhinge A., Chandran V. Effect of cationic amino acid L-lysine and its polymers on the growth and secretion of hybridoma cell line OKT3. Hybridoma. 19(4):2000;339-346.
15. Powell MF, Newman MJ. Vaccine design - the subunit and adjuvant approach. New York: Plenum Press; 1995.
16. Calder P.C., Yaqoob P. Glutamine and the immune system. Amino Acids. 17(3):1999;227-241.
17. Newsholme E.A., Calder P.C. The proposed role of glutamine in some cells of the immune system and speculative consequences for the whole animal. Nutrition. 13(7-8):1997;728-730.
18. de Gruijl T.D., Moore J.J., de Vries E., von Blomberg-van der Flier B.M., Fonk J.C., Scheper R.J. Augmentation of antigen-specific lymphoproliferative responses in vitro by biological response modifiers. Clin. Exp. Immunol. 96(3):1994;535-540.
19. Datta D., Kundu P.K., Senthilkumar M. Studies in high density culture of hybridoma cells (AE9D6) in vitro. Artif. Organs. 21(6):1997;534.
20. Datta D., Kundu P.K., Senthilkumar M. Effect of L-lysine on the growth and secretion of hybridoma cell (AE9D6). Biotechnol. Tech. 11(9):1997;617-620.